| Epitope ID
∧
∨
|
Epitope name
∧
∨
|
Sequence
∧
∨
|
| EP0103 |
Poly-KDN |
(KDN)n |
| EP0101 |
Poly-N-Acetylneuraminic Acid |
(Neu5Ac) n |
| EP0102 |
Poly-N-Glycolylneuraminic Acid |
(Neu5Gc)n |
| EP0506 |
beta 1-4 Galactan |
-[Gal(b1-4)]n- |
| EP0507 |
1-6 beta Galactan |
-[Gal(b1-6)]n- |
| EP0500 |
Homogalacturonan |
-[GalA(a1-4)]n- O-acetyled and methyl-esterified GalA may exist |
| EP0081 |
Chondroitin |
-[GlcA(b1-3)GalNAc(b1-4)]n- |
| EP0086 |
Heparan Sulfate |
-[{[±(HSO3(-2))GlcA(b1-4)]or[±(HSO3(-2))IdoA(a1-4)]}(±(HSO3(-3))±[(HSO3 or CH3CO)(-2)]±(HSO3(-6))GlcN]n- |
| EP0082 |
Chondroitin-4-Sulfate |
-{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
| EP0083 |
Chondroitin-6-Sulfate |
-{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
| EP0085 |
Keratan Sulfate |
-{HSO3(-6)GlcNAc(b1-3)±[HSO3(-6)]Gal(b1-4)}n- |
| EP0084 |
Chindroitin Sulfate D Unit |
-{[HSO3(-2)]GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
| EP0088 |
Acharan Sulfate |
-{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- |
| EP0250 |
Blood Group H Disaccharide |
Fuc(a1-2)Gal(b1-)-R |
| EP0253 |
Blood Group H Type 3 |
Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R |
| EP0254 |
Blood Group H Type 4 |
Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| EP0057 |
Fucosyl Asialo-GM1 |
Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer |
| EP0049 |
Fucosyl GM1 |
Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
| EP0251 |
Blood Group H Type 1 |
Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R |
| EP0010 |
Lewis b |
Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
| EP0092 |
Trifucosyl-Lewis b Antigen |
Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
| EP0252 |
Blood Group H Type 2 |
Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R |
| EP0018 |
Lewis y |
Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
| EP0210 |
Lewis y (extended) / Hexasaccharide |
Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)GlcNAc-R |
| EP0094 |
Trifucosyl-Lewis y Antigen |
Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
